tirzepatide vs retatrutide Compared Retatrutide vs tirzepatide for weight

Multiple community reports support this observation, particularly during the higher-dose phases of the escalation schedule

The outcomes were defined using descriptive system measures of five domains (mobility, self-care, usual activities, pain or discomfort, anxiety, or depression), each with five levels of severity

Saxenda specifically licensed for weight management) Dulaglutide (Trulicity, licensed only for diabetes, not weight management) Tirzepatide (Mounjaro), a dual GLP-1 and GIP receptor agonist licensed for type 2 diabetes These medications are administered via subcutaneous injection, typically weekly or daily depending on the specific formulation

Osteoporos Int 31(12):23132320